As reported previously for CRC patients, the TME is predominantly infiltrated with circulating regulatory T cells (Tregs)21,22 that inhibit the activity of CD4 + T helper cells (Th) and CTLs23,24. The gene discussed is CD4; the disease is colorectal carcinoma.